Conference abstract · 24 Oct 2018
Conference abstractPublished 24 Oct 2018
Biosimilars Analytical Strategies
Chong Kun Dang Pharmaceuticals, SOuth Korea
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biosimilar products (follow-on versions of pioneering biopharmaceutical products which is already licensed) are complex structurally and functionally. Regulatory authorities require biosimilars to have appropriate and comparable safety, quality, and efficacy with a corresponding reference biologic product. In order to investigate the critical quality attributes of a biosimilar and a reference product for interchangeability and comparability, various analytical approaches are employed, such as LC/MS, Peptide mapping, Thermal analysis, SDS-PAGE, Isoelectric focusing and Capillary isoelectric focusing, Particulate matter analysis, In-vivo and In-vitro bioassay, etc. Analytical similarity of a biosimilar to a reference biological product is assessed with the state-of-the-art of analytical strategies. One of the key analytical techniques is Mass Spectrometry (MS) for assessment of similarity, detection and identification of primary sequence differences, and evaluation of batch variability. Analytical differences observed need to be characterized and understood for a cross-confirmation of the data using orthogonal methods to prove the differences are not clinically relevant. Post-translational modifications, three-dimensional structures, and protein aggregation have been identified as three important characteristics in development strategies for biosimilar. For quality control of the biosimilar production process and product, in-process samples, drug substance, and drug product is evaluated in terms of protein content, purity, potency, identity, and impurity. All analytical data includes the stability study data impact on clinical trials, the product expiration date, and the product approval.
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Oct 2018
Biosimilars analytical strategies
Conference abstract · 27 Oct 2014
Analytical biosimilarity: Strategies and challenges
Editorial · 29 Oct 2024
Quality Control of Biosimilars: Regulatory Challenges and Analytical Approaches
Short communication · 8 Nov 2021
Implications of analytical tools for biosimilars
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectChemistry
- BylineArticles whose byline prints “Sung Nyeo Shim”
